E‐cadherin is downregulated in benign prostatic hyperplasia and required for tight junction formation and permeability barrier in the prostatic epithelial cell monolayer-Reference-Cited by-同舟云学术

E‐cadherin is downregulated in benign prostatic hyperplasia and required for tight junction formation and permeability barrier in the prostatic epithelial cell monolayer

Published:2019-06-18 Issue:11 Volume:79 Page:1226-1237
ISSN:0270-4137
Container-title:The Prostate
language:en
Short-container-title:Prostate

Author:

Li Feng¹²³,Pascal Laura E.³^ORCID,Stolz Donna B.⁴,Wang Ke¹³,Zhou Yibin³⁵,Chen Wei³,Xu Yadong³⁶,Chen Yule¹,Dhir Rajiv⁷,Parwani Anil V.⁷,Nelson Joel B.³,DeFranco Donald B.⁸⁹,Yoshimura Naoki³,Balasubramani Goundappa K.¹⁰,Gingrich Jeffrey R.³,Maranchie Jodi K.³,Jacobs Bruce L.³,Davies Benjamin J.³,Hrebinko Ronald L.³,Bigley Joel D.³,McBride Dawn³,Guo Peng¹,He Dalin¹,Wang Zhou³⁹¹¹

Affiliation:

1. Department of UrologyThe First Affiliated Hospital of Xi'an Jiaotong UniversityXi'an Shaanxi China

2. Department of UrologyThe Second Affiliated Hospital of Xi'an Jiaotong UniversityXi'an Shaanxi China

3. Department of UrologyUniversity of Pittsburgh School of MedicinePittsburgh Pennsylvania

4. Department of Cell BiologyUniversity of Pittsburgh School of MedicinePittsburgh Pennsylvania

5. Department of UrologyThe Second Affiliated Hospital of Soochow UniversitySuzhou Jiangsu China

6. Department of UrologyThe Second Affiliated Hospital of Centre West UniversityChangsha Hunan China

7. Department of PathologyUniversity of Pittsburgh School of MedicinePittsburgh Pennsylvania

8. Pittsburgh Institute for Neurodegenerative Diseases, Department of NeurologyUniversity of Pittsburgh School of MedicinePittsburgh Pennsylvania

9. Department of Pharmacology and Chemical BiologyUniversity of Pittsburgh School of MedicinePittsburgh Pennsylvania

10. Department of Epidemiology, Epidemiology Data CenterUniversity of PittsburghPittsburgh Pennsylvania

11. UPMC Hillman Cancer Center, UPMCUniversity of Pittsburgh School of MedicinePittsburgh Pennsylvania

Funder

Foundation for the National Institutes of Health

National Institute of Diabetes and Digestive and Kidney Diseases

China Scholarship Council

Publisher

Wiley

Subject

Urology,Oncology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/pros.23806

Reference49 articles.

1. Cumulative prevalence of prostatism matches the autopsy prevalence of benign prostatic hyperplasia

2. Treatment of Concomitant OAB and BPH

3. The economics of benign prostatic hyperplasia and lower urinary tract symptoms in the united states

4. Promising Molecular Targets and Biomarkers for Male BPH and LUTS

5. Androgen Receptor Roles in the Development of Benign Prostate Hyperplasia

Cited by 15 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Mechanisms of LPS–induced epithelial mesenchymal transition in bEECs;Theriogenology;2024-03

2. Diacerein provokes apoptosis, improves redox balance, and downregulates PCNA and TNF-α in a rat model of testosterone-induced benign prostatic hyperplasia: A new non-invasive approach;PLOS ONE;2023-11-09

3. The Multifaceted Role of Osteopontin in Prostate Pathologies;Biomedicines;2023-10-26

4. The blood-prostate barrier: an obstacle to drug delivery into the prostate;Current Drug Delivery;2023-08-07

5. Simvastatin Improves Benign Prostatic Hyperplasia: Role of Peroxisome-Proliferator-Activated Receptor-γ and Classic WNT/β-Catenin Pathway;International Journal of Molecular Sciences;2023-03-03